Bernard Pécoul

Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland.

Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland.

Médecins Sans Frontières (UK) is a non-profit organization that was founded in 1971. The non-profit company is based in London, UK. MSF provides vital medical care to people in over 65 countries who are affected by wars, natural disasters, and epidemics. The British company offers affordable access to high-quality education in tropical medicine through a part-time course. MSF relies on private individuals and organizations for 100% of their donations, and their network of fundraisers helps them deliver life-saving care across the world. The company's commitment to offering high-quality medical care in challenging settings has made research and innovation a part of their lifeblood.